Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allendale Pharmaceuticals was a specialty pharmaceutical company primarily known for acquiring and relaunching the Today Sponge, a popular over-the-counter female contraceptive. The company focused on women's healthcare and reproductive health products, specifically targeting non-hormonal options. After successfully navigating the regulatory hurdles to bring the Today Sponge back to the U.S. market in 2005, the company was acquired by Synova Healthcare in 2007. Its business model centered on the commercialization of established but underserved consumer health brands. The relaunch was highly anticipated due to the product's previous market dominance and cultural significance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allendale Pharmaceuticals.